Info
This podcast will feature host Dr. Stephen Gately, PhD, President & CEO of TD2, as he discusses the complex challenges of drug development and innovative technologies in a new podcast...
mostra di piùEvolution and Innovation in Oncology Therapeutics Development
Evolution and Innovation in Oncology Therapeutics Development
Industry Dive's studioIDBiomarkers and the Utility of Proteomics for Dose Optimization and Confirmation of Target Engagement
This podcast will feature host Dr. Stephen Gately, PhD, President & CEO of TD2, as he discusses the complex challenges of drug development and innovative technologies in a new podcast...
mostra di piùInformazioni
Autore | Industry Dive's studioID |
Organizzazione | Industry Dive's studioID |
Categorie | Medicina |
Sito | - |
- |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company